Application 1107
Acticon artificial bowel sphincter
Application No. | 1107 |
| Application Name | Acticon artificial bowel sphincter |
| Advisory Panel | Dr Mary Turner (Chair and MSAC member) Professor Brendon Kearney (MSAC member) Dr David Jarvis (Royal Australian College of General Practice nominee) Dr Matt Rickard (Royal Australian College of Surgeons and Colorectal Surgical Society of Australia nominee) Assoc Professor David Fonda (Co-opted member) Ms Sheila Rimmer (Consumers Health Forum nominee) |
| Date Received by MSAC Secretariat | 14 June 2006 |
| Stage 1 - Eligibility | Eligible |
| Stage 2 - Assessment | Completed |
| Stage 3 - Formulation of Advice to the Minister | This assessment was considered by the MSAC at the 23 November 2007 meeting. MSAC has considered the safety, effectiveness and cost-effectiveness for implantation of the Acticon Artificial Bowel Sphincter (AABS) compared with conservative management, colostomy and dynamic graciloplasty. MSAC finds that there is no evidence comparing AABS with colostomy and limited evidence comparing it with conservative management and dynamic graciloplasty. MSAC finds that the evidence suggests that AABS implantation is not as safe as conservative management and that it is likely to be at least as safe as dynamic graciloplasty. MSAC finds that the evidence indicates that AABS is more clinically effective than both conservative management and dynamic graciloplasty. MSAC finds that relative cost effectiveness of AABS and the comparators could not be assessed due to lack of data. The comparison of the estimated total costs indicates that the cost to the health system for AABS is less than for dynamic graciloplasty. MSAC recommends that public funding is supported for this procedure. |
| Stage 4 - Decision | Accepted by the Minister for Health and Ageing on 11 April 2008 |
| Stage 5 - Implementation |  |